Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells

Molecular Therapy

Volumn 21, Issue 6, 2013, Pages 1242-1250

  Liao, Jiyuan ^a   Marumoto, Tomotoshi ^a,b   Yamaguchi, Saori ^a   Okano, Shinji ^a   Takeda, Naoki ^c   Sakamoto, Chika ^a   Kawano, Hirotaka ^a   Nii, Takenobu ^a   Miyamato, Shohei ^a   Nagai, Yoko ^a   Okada, Michiyo ^a   Inoue, Hiroyuki ^a,b   Kawahara, Kohichi ^a   Suzuki, Akira ^a   Miura, Yoshie ^a   Tani, Kenzaburo ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPOTASSIUM BISPEROXO(5 HYDROXYPYRIDINE 2 CARBOXYL)OXOVANADIC ACID; ENZYME INHIBITOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL RENEWAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FIBROBLAST CULTURE; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SOMATIC CELL;

EID: 84878600256     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.60     Document Type: Article

References (50)

1. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126: 663-676.
2. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K et al. (2007). Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131: 861-872.
3. Yu, J, Vodyanik, MA, Smuga-Otto, K, Antosiewicz-Bourget, J, Frane, JL, Tian, S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
4. Nakagawa, M, Koyanagi, M, Tanabe, K, Takahashi, K, Ichisaka, T, Aoi, T et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fbroblasts. Nat Biotechnol 26: 101-106.
5. Wernig, M, Meissner, A, Foreman, R, Brambrink, T, Ku, M, Hochedlinger, K et al. (2007). In vitro reprogramming of fbroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
6. Esteban, MA, Wang, T, Qin, B, Yang, J, Qin, D, Cai, J et al. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6: 71-79.
7. Stadtfeld, M and Hochedlinger, K (2010). Induced pluripotency: history, mechanisms, and applications. Genes Dev 24: 2239-2263.
8. Hanna, J, Saha, K, Pando, B, van Zon, J, Lengner, CJ, Creyghton, MP et al. (2009). Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462: 595-601.
9. Storm, M P, Bone, HK, Beck, CG, Bourillot, PY, Schreiber, V, Damiano, T et al. (2007). Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem 282: 6265-6273.
10. Jeong, CH, Cho, YY, Kim, MO, Kim, SH, Cho, EJ, Lee, SY et al. (2010). Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells 28: 2141-2150.
11. Chen, L and Khillan, JS (2010). A novel signaling by vitamin A/retinol promotes self renewal of mouse embryonic stem cells by activating PI3K/Akt signaling pathway via insulin-like growth factor-1 receptor. Stem Cells 28: 57-63.
12. Okita, K, Ichisaka, T and Yamanaka, S (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
13. Stambolic, V, Suzuki, A, de la Pompa, JL, Brothers, GM, Mirtsos, C, Sasaki, T et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39.
14. Myers, MP, Pass, I, Batty, IH, Van der Kaay, J, Stolarov, JP, Hemmings, BA et al. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513-13518.
15. Sun, H, Lesche, R, Li, DM, Liliental, J, Zhang, H, Gao, J et al. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96: 6199-6204.
16. Salmena, L, Carracedo, A and Pandolf, PP (2008). Tenets of PTEN tumor suppression. Cell 133: 403-414.
17. Alva, JA, Lee, GE, Escobar, EE and Pyle, AD (2011). Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells. Stem Cells 29: 1952-1962.
18. Di Cristofano, A, Pesce, B, Cordon-Cardo, C and Pandolf, PP (1998). Pten is essential for embryonic development and tumour suppression. Nat Genet 19: 348-355.
19. Higuchi, M, Masuyama, N, Fukui, Y, Suzuki, A and Gotoh, Y (2001). Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells. Curr Biol 11: 1958-1962.
20. Solter, D and Knowles, BB (1978). Monoclonal antibody defning a stage-specifc mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75: 5565-5569.
21. Maehama, T and Dixon, JE (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273: 13375-13378.
22. Li, DM and Sun, H (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129.
23. Watanabe, S, Umehara, H, Murayama, K, Okabe, M, Kimura, T and Nakano, T (2006). Activation of Akt signaling is suffcient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25: 2697-2707.
24. Kimura, T, Suzuki, A, Fujita, Y, Yomogida, K, Lomeli, H, Asada, N et al. (2003). Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130: 1691-1700.
25. Posner, BI, Faure, R, Burgess, JW, Bevan, AP, Lachance, D, Zhang-Sun, G et al. (1994). Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596-4604.
26. Salh, B, Wagey, R, Marotta, A, Tao, JS and Pelech, S (1998). Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J Immunol 161: 6947-6954.
27. Zhu, S, Li, W, Zhou, H, Wei, W, Ambasudhan, R, Lin, T et al. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7: 651-655.
28. Huangfu, D, Maehr, R, Guo, W, Eijkelenboom, A, Snitow, M, Chen, AE et al. (2008). Induction of pluripotent stem cells by defned factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
29. Silva, J, Barrandon, O, Nichols, J, Kawaguchi, J, Theunissen, TW and Smith, A (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253.
30. Lin, T, Ambasudhan, R, Yuan, X, Li, W, Hilcove, S, Abujarour, R et al. (2009). A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808.
31. Maherali, N, Sridharan, R, Xie, W, Utikal, J, Eminli, S, Arnold, K et al. (2007). Directly reprogrammed fbroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
32. Zhu, J, Blenis, J and Yuan, J (2008). Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci USA 105: 6584-6589.
33. Hong, H, Takahashi, K, Ichisaka, T, Aoi, T, Kanagawa, O, Nakagawa, M et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135.
34. Liang, G, He, J and Zhang, Y (2012). Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol 14: 457-466.
35. Aparicio, IM, Garcia-Herreros, M, Fair, T and Lonergan, P (2010). Identifcation and regulation of glycogen synthase kinase-3 during bovine embryo development. Reproduction 140: 83-92.
36. Wang, Q, Xu, X, Li, J, Liu, J, Gu, H, Zhang, R et al. (2011). Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res 21: 1424-1435.
37. Chen, T, Shen, L, Yu, J, Wan, H, Guo, A, Chen, J et al. (2011). Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 10: 908-911.
38. Kawamura, T, Suzuki, J, Wang, YV, Menendez, S, Morera, LB, Raya, A et al. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
39. Utikal, J, Polo, JM, Stadtfeld, M, Maherali, N, Kulalert, W, Walsh, RM et al. (2009). Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148.
40. Li, H, Collado, M, Villasante, A, Strati, K, Ortega, S, Cañamero, M et al. (2009). The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139.
41. Banito, A, Rashid, ST, Acosta, JC, Li, S, Pereira, CF, Geti, I et al. (2009). Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23: 2134-2139.
42. Marión, RM, Strati, K, Li, H, Murga, M, Blanco, R, Ortega, S et al. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153.
43. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S et al. (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specifc iPSCs. Nature. doi:10.1038/nature11799
44. Zhang, J, Nuebel, E, Daley, GQ, Koehler, CM and Teitell, MA (2012). Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal. Cell Stem Cell 11: 589-595.
45. Britton, JS, Lockwood, WK, Li, L, Cohen, SM and Edgar, BA (2002). Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev Cell 2: 239-249.
46. Hollander, MC, Blumenthal, GM and Dennis, PA (2011). PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11: 289-301.
47. Kitamura, T, Koshino, Y, Shibata, F, Oki, T, Nakajima, H, Nosaka, T et al. (2003). Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31: 1007-1014.
48. Morita, S, Kojima, T and Kitamura, T (2000). Plat-E: an effcient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
49. Blelloch, R, Wang, Z, Meissner, A, Pollard, S, Smith, A and Jaenisch, R (2006). Reprogramming effciency following somatic cell nuclear transfer is infuenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24: 2007-2013.
50. Kang, L, Wang, J, Zhang, Y, Kou, Z and Gao, S (2009). iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5: 135-138.